tm logo
Trademark Search
CESTRATA

View On IC.GC.CA

CESTRATA
REGISTERED

on 26 Sep 2019

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks, CA 91320-1799

US

Serial Number

1830767 filed on 03rd Apr 2017

Registration Number

TMA1056429 registered on 26th Sep 2019

Registration expiry Date

26th Sep 2029

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

CESTRATA

Trademark usage description

pharmaceutical preparations for use in the treatment of cancer, malignant tumours and for suppressing tumors; pharmaceutical preparations for use in t Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in the treatment of cancer, malignant tumours and for suppressing tumors; pharmaceutical preparations for use in the treatment of autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis and Huntington's disease; pharmaceutical preparations for use in the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; and pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders.

Classification kind code

10

Mark Details

Serial Number

1830767

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 04th Jan 2019		Allowed
Submitted for opposition 42
on 19th Sep 2018		Advertised
Submitted for opposition 26
on 30th Aug 2018		Approved
Submitted for opposition 27
on 13th Jul 2018		Approval Notice Sent
Submitted for opposition 15
on 23rd Feb 2018		Correspondence Created
Submitted for opposition 22
on 21st Aug 2017		Search Recorded
Submitted for opposition 20
on 21st Aug 2017		Examiner's First Report
Submitted for opposition 31
on 10th Apr 2017		Formalized
Submitted for opposition 1
on 04th Apr 2017		Created
Submitted for opposition 30
on 03rd Apr 2017		Filed